Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesař

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Kidney International Reports|September 14, 2023
Challenges in IgA Nephropathy Management: An Era of Complement InhibitionVladimir Tesař, Jai Radhakrishnan, Vivek Charu, et al.
Nature Reviews. Disease Primers|November 30, 2023
IgA nephropathyEleni Stamellou, Claudia Seikrit, Sydney C W Tang, et al.
BMC Nephrology|July 13, 2013
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational studyMartina Peiskerová, Marta Kalousová, Vilem Danzig, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
The Lancet. Rheumatology|August 25, 2024
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohortKarl Gisslander, Arthur White, Louis Aslett, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Clinical Kidney Journal|February 11, 2021
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology communityMehmet Şükrü Sever, Kitty J Jager, Raymond Vanholder, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
The New England Journal of Medicine|July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitisPaul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Kidney International Reports|September 14, 2023
Challenges in IgA Nephropathy Management: An Era of Complement InhibitionVladimir Tesař, Jai Radhakrishnan, Vivek Charu, et al.
Nature Reviews. Disease Primers|November 30, 2023
IgA nephropathyEleni Stamellou, Claudia Seikrit, Sydney C W Tang, et al.
BMC Nephrology|July 13, 2013
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational studyMartina Peiskerová, Marta Kalousová, Vilem Danzig, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
The Lancet. Rheumatology|August 25, 2024
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohortKarl Gisslander, Arthur White, Louis Aslett, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Clinical Kidney Journal|February 11, 2021
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology communityMehmet Şükrü Sever, Kitty J Jager, Raymond Vanholder, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
The New England Journal of Medicine|July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitisPaul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Pageof 1